You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Cdk4 antibody [DCS-31] (ab6315)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-Cdk4 antibody [DCS-31]
See all Cdk4 products (19) ...

Description

Mouse monoclonal [DCS-31] to Cdk4

Specificity

Reacts specifically with Cdk4. Does not recognise other Cdk types.

Tested applications

WB, IP, ICC, Flow Cytmore details

Cross reactivity

Reacts with

Mouse, Rat, Human

Immunogen

Recombinant full length protein (Human).

Properties

Form

Liquid

Storage instructions

Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Ascitic fluid with 15mM sodium azide

Concentration

Concentration information loading...

Purity

Ascites

Clonality

Monoclonal

Clone number

DCS-31

Isotype

IgG2a

  • Flow Cytometry - Cdk4 antibody [DCS-31] (ab6315)Flow Cytometry - Cdk4 antibody [DCS-31] (ab6315) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab6315 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Target

Function

Ser/Thr-kinase component of cyclin D-CDK4 (DC) complexes that phosphorylate and inhibit members of the retinoblastoma (RB) protein family including RB1 and regulate the cell-cycle during G(1)/S transition. Phosphorylation of RB1 allows dissociation of the transcription factor E2F from the RB/E2F complexes and the subsequent transcription of E2F target genes which are responsible for the progression through the G(1) phase. Hypophosphorylates RB1 in early G(1) phase. Cyclin D-CDK4 complexes are major integrators of various mitogenenic and antimitogenic signals. Also phosphorylates SMAD3 in a cell-cycle-dependent manner and represses its transcriptional activity. Component of the ternary complex, cyclin D/CDK4/CDKN1B, required for nuclear translocation and activity of the cyclin D-CDK4 complex.

Involvement in disease

Defects in CDK4 are a cause of susceptibility to cutaneous malignant melanoma type 3 (CMM3) [MIM:609048]. Malignant melanoma is a malignant neoplasm of melanocytes, arising de novo or from a pre-existing benign nevus, which occurs most often in the skin but also may involve other sites.

Sequence similarities

Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. CDC2/CDKX subfamily.
Contains 1 protein kinase domain.

Post-translational
modifications

Phosphorylation at Thr-172 is required for enzymatic activity. Phosphorylated, in vitro, at this site by CCNH-CDK7, but, in vivo, appears to be phosphorylated by a proline-directed kinase. In the cyclin D-CDK4-CDKN1B complex, this phosphorylation and consequent CDK4 enzyme activity, is dependent on the tyrosine phosphorylation state of CDKN1B. Thus, in proliferating cells, CDK4 within the complex is phosphorylated on Thr-172 in the T-loop. In resting cells, phosphorylation on Thr-172 is prevented by the non-tyrosine-phosphorylated form of CDKN1B.

Cellular localization

Cytoplasm. Nucleus. Membrane. Cytoplasmic when non-complexed. Forms a cyclin D-CDK4 complex in the cytoplasm as cells progress through G(1) phase. The complex accumulates on the nuclear membrane and enters the nucleus on transition from G(1) to S phase. Also present in nucleoli and heterochromatin lumps. Colocalizes with RB1 after release into the nucleus.

Target information above from: UniProt accessionP11802 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • Cdk 4 antibody
  • cdk4 antibody
  • CDK4 protein antibody
  • CDK4_HUMAN antibody
  • Cell division kinase 4 antibody
  • Cell division protein kinase 4 antibody
  • CMM 3 antibody
  • CMM3 antibody
  • Crk3 antibody
  • Cyclin dependent kinase 4 antibody
  • Cyclin-dependent kinase 4 antibody
  • Melanoma cutaneous malignant 3 antibody
  • MGC14458 antibody
  • p34 cdk4 antibody
  • PSK J3 antibody
  • PSK-J3 antibody
see all

Anti-Cdk4 antibody [DCS-31] images:

  Flow Cytometry - Cdk4 antibody [DCS-31] (ab6315)

Flow Cytometry - Cdk4 antibody [DCS-31] (ab6315)

ab6315 staining human MDA-MB-436 breast cancer cells by Flow Cytometery. Cells were treated with Trypsin/EDTA for 5 minutes, sample buffer prepared as 5%FCS in PBS and gating was done on live non apoptotic cells. The primary antibody diluted 1/500 and incubated with sample for 1 hour at 4°C. A FITC conjugated horse polyclonal to mouse IgG, diluted 1/200 was used as secondary

Penelope Ottewell, Org unknown, Country unknown

References for Anti-Cdk4 antibody [DCS-31] (ab6315)

This product has been referenced in:

  • Boutant M  et al. COUP-TFII Controls Mouse Pancreatic ß-Cell Mass through GLP-1-ß-Catenin Signaling Pathways. PLoS One 7:e30847 (2012). WB; Mouse.Read more (PubMed: 22292058) »
  • Ottewell PD  et al. Anticancer mechanisms of doxorubicin and zoledronic acid in breast cancer tumor growth in bone. Mol Cancer Ther 8:2821-32 (2009). WB; Mouse.Read more (PubMed: 19789217) »

See all 2 publications for this product

Publishing research using ab6315? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"